CAMZYOS is a Oral Capsule, Gelatin Coated in the Cellular Therapy category. It is labeled and distributed by Myokardia, Inc.. The primary component is Mavacamten.
Product ID | 73625-111_175808e7-ba8b-49b6-bc26-3de9d98ecfd4 |
NDC | 73625-111 |
Product Type | Cellular Therapy |
Proprietary Name | CAMZYOS |
Generic Name | Mavacamten |
Dosage Form | Capsule, Gelatin Coated |
Route of Administration | ORAL |
Marketing Start Date | 2022-04-28 |
Marketing Category | NDA / |
Application Number | NDA214998 |
Labeler Name | Myokardia, Inc. |
Substance Name | MAVACAMTEN |
Active Ingredient Strength | 3 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-04-28 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
73625-111 | CAMZYOS | mavacamten |
73625-112 | CAMZYOS | mavacamten |
73625-113 | CAMZYOS | mavacamten |
73625-114 | CAMZYOS | mavacamten |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CAMZYOS 98478203 not registered Live/Pending |
MyoKardia, Inc. 2024-04-01 |
CAMZYOS 97539194 not registered Live/Pending |
MyoKardia, Inc. 2022-08-08 |
CAMZYOS 90463748 not registered Live/Pending |
MyoKardia, Inc. 2021-01-13 |
CAMZYOS 88693134 not registered Live/Pending |
MyoKardia, Inc. 2019-11-14 |